Human Challenge Studies in Endemic Settings : : Ethical and Regulatory Issues.

Saved in:
Bibliographic Details
Superior document:SpringerBriefs in Ethics Series
:
TeilnehmendeR:
Place / Publishing House:Cham : : Springer International Publishing AG,, 2020.
©2021.
Year of Publication:2020
Edition:1st ed.
Language:English
Series:SpringerBriefs in Ethics Series
Online Access:
Physical Description:1 online resource (145 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 5006310312
ctrlnum (MiAaPQ)5006310312
(Au-PeEL)EBL6310312
(OCoLC)1243532476
collection bib_alma
record_format marc
spelling Jamrozik, Euzebiusz.
Human Challenge Studies in Endemic Settings : Ethical and Regulatory Issues.
1st ed.
Cham : Springer International Publishing AG, 2020.
©2021.
1 online resource (145 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
SpringerBriefs in Ethics Series
Intro -- Preface -- Acknowledgments -- Executive Summary -- Background -- Key Points of Consensus -- Unresolved Issues -- Conclusion -- Contents -- 1 Introduction -- 1.1 Focus of This Report -- 1.2 Methods -- 1.2.1 Literature Review -- 1.2.2 Qualitative Interviews -- 1.2.3 Synthesis and Validity Checking -- References -- 2 History of Human Challenge Studies -- 2.1 Experimental Infection in the 18th-19th Century -- 2.2 Early Challenge Studies with Vector-Borne Diseases -- 2.3 Malariotherapy -- 2.4 Infamous 20th Century Cases and the Rise of Modern Research Ethics -- 2.5 Late 20th Century -- 2.6 Capacity Building in Low- and Middle-Income Countries -- References -- 3 Ethical Issues -- 3.1 Intentional Infection -- 3.2 Benefits -- 3.2.1 Scientific Rationale and Social Value -- 3.2.2 Benefit Sharing -- 3.2.3 Capacity Building -- 3.2.4 Potential Individual Benefits of Participation in Endemic Settings -- 3.3 Burdens for Participants -- 3.3.1 Limits to Risk -- 3.3.2 Minimising Risks -- 3.3.3 Risks to Participants in Endemic Settings -- 3.3.4 Long-Term Risks and Lasting Harms -- 3.3.5 Uncertainty -- 3.3.6 Other Burdens for Participants -- 3.3.7 Participant Behaviour -- 3.4 Risks to Third Parties -- 3.4.1 Third-Party Risks and Studies of Transmissibility -- 3.5 Participant Selection -- 3.5.1 Vulnerable Populations in Human Challenge Studies -- 3.5.2 Consent -- 3.5.3 Education Level -- 3.5.4 Children -- 3.6 Payment of Participants -- 3.6.1 Undue Inducement -- 3.6.2 Other Ethical Issues Related to Payment -- References -- 4 Community Engagement, Ethics Review, and Regulation -- 4.1 Community Engagement -- 4.2 Ethical Review -- 4.2.1 Ethical Frameworks for Human Challenge Studies -- 4.2.2 Potential Models for Special Ethical Review -- 4.3 Regulation -- 4.3.1 International Regulations -- 4.3.2 Regulating Challenge Strains.
4.3.3 Challenge Studies and Licensure of New Interventions -- 4.3.4 Regulation of Over-Volunteering -- 4.3.5 Laws Criminalising Intentional Infection -- References -- 5 Case Studies: Challenge Studies in Low- and Middle-Income Countries -- 5.1 Cholera and Shigella Challenge Studies in Thailand -- 5.1.1 Rationale and Review Process -- 5.1.2 Recruitment, Participant Selection, Consent, and Payment -- 5.1.3 Burdens (Including Risks to Participants and Third Parties) -- 5.1.4 Summary and Outcomes -- 5.2 Falciparum Malaria Challenge Studies in Africa -- 5.2.1 Rationale and Review Process -- 5.2.2 Recruitment, Participant Selection, Consent, and Payment -- 5.2.3 Burdens (Including Risks to Participants and Third Parties) -- 5.2.4 Summary and Outcomes -- 5.3 Vivax Malaria Challenge Studies in Colombia -- 5.3.1 Rationale and Review Process -- 5.3.2 Recruitment, Participant Selection, Consent, and Payment -- 5.3.3 Burdens (Including Risks to Participants and Third Parties) -- 5.3.4 Summary and Outcomes -- 5.4 Summary of Case Studies -- 5.4.1 Rationale and Review Process -- 5.4.2 Recruitment, Participant Selection, Consent, and Payment -- 5.4.3 Burdens (Including Risks to Participants and Third Parties) -- References -- 6 Conclusions -- 6.1 Lessons Learned to Date -- 6.2 Points of Consensus -- 6.3 Controversies and Unresolved Issues -- 6.3.1 Burdens and Benefits -- 6.3.2 Participant Selection and Payment -- 6.3.3 Governance -- 6.4 Future Directions -- References.
Description based on publisher supplied metadata and other sources.
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
Electronic books.
Selgelid, Michael J.
Print version: Jamrozik, Euzebiusz Human Challenge Studies in Endemic Settings Cham : Springer International Publishing AG,c2020 9783030414795
ProQuest (Firm)
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6310312 Click to View
language English
format eBook
author Jamrozik, Euzebiusz.
spellingShingle Jamrozik, Euzebiusz.
Human Challenge Studies in Endemic Settings : Ethical and Regulatory Issues.
SpringerBriefs in Ethics Series
Intro -- Preface -- Acknowledgments -- Executive Summary -- Background -- Key Points of Consensus -- Unresolved Issues -- Conclusion -- Contents -- 1 Introduction -- 1.1 Focus of This Report -- 1.2 Methods -- 1.2.1 Literature Review -- 1.2.2 Qualitative Interviews -- 1.2.3 Synthesis and Validity Checking -- References -- 2 History of Human Challenge Studies -- 2.1 Experimental Infection in the 18th-19th Century -- 2.2 Early Challenge Studies with Vector-Borne Diseases -- 2.3 Malariotherapy -- 2.4 Infamous 20th Century Cases and the Rise of Modern Research Ethics -- 2.5 Late 20th Century -- 2.6 Capacity Building in Low- and Middle-Income Countries -- References -- 3 Ethical Issues -- 3.1 Intentional Infection -- 3.2 Benefits -- 3.2.1 Scientific Rationale and Social Value -- 3.2.2 Benefit Sharing -- 3.2.3 Capacity Building -- 3.2.4 Potential Individual Benefits of Participation in Endemic Settings -- 3.3 Burdens for Participants -- 3.3.1 Limits to Risk -- 3.3.2 Minimising Risks -- 3.3.3 Risks to Participants in Endemic Settings -- 3.3.4 Long-Term Risks and Lasting Harms -- 3.3.5 Uncertainty -- 3.3.6 Other Burdens for Participants -- 3.3.7 Participant Behaviour -- 3.4 Risks to Third Parties -- 3.4.1 Third-Party Risks and Studies of Transmissibility -- 3.5 Participant Selection -- 3.5.1 Vulnerable Populations in Human Challenge Studies -- 3.5.2 Consent -- 3.5.3 Education Level -- 3.5.4 Children -- 3.6 Payment of Participants -- 3.6.1 Undue Inducement -- 3.6.2 Other Ethical Issues Related to Payment -- References -- 4 Community Engagement, Ethics Review, and Regulation -- 4.1 Community Engagement -- 4.2 Ethical Review -- 4.2.1 Ethical Frameworks for Human Challenge Studies -- 4.2.2 Potential Models for Special Ethical Review -- 4.3 Regulation -- 4.3.1 International Regulations -- 4.3.2 Regulating Challenge Strains.
4.3.3 Challenge Studies and Licensure of New Interventions -- 4.3.4 Regulation of Over-Volunteering -- 4.3.5 Laws Criminalising Intentional Infection -- References -- 5 Case Studies: Challenge Studies in Low- and Middle-Income Countries -- 5.1 Cholera and Shigella Challenge Studies in Thailand -- 5.1.1 Rationale and Review Process -- 5.1.2 Recruitment, Participant Selection, Consent, and Payment -- 5.1.3 Burdens (Including Risks to Participants and Third Parties) -- 5.1.4 Summary and Outcomes -- 5.2 Falciparum Malaria Challenge Studies in Africa -- 5.2.1 Rationale and Review Process -- 5.2.2 Recruitment, Participant Selection, Consent, and Payment -- 5.2.3 Burdens (Including Risks to Participants and Third Parties) -- 5.2.4 Summary and Outcomes -- 5.3 Vivax Malaria Challenge Studies in Colombia -- 5.3.1 Rationale and Review Process -- 5.3.2 Recruitment, Participant Selection, Consent, and Payment -- 5.3.3 Burdens (Including Risks to Participants and Third Parties) -- 5.3.4 Summary and Outcomes -- 5.4 Summary of Case Studies -- 5.4.1 Rationale and Review Process -- 5.4.2 Recruitment, Participant Selection, Consent, and Payment -- 5.4.3 Burdens (Including Risks to Participants and Third Parties) -- References -- 6 Conclusions -- 6.1 Lessons Learned to Date -- 6.2 Points of Consensus -- 6.3 Controversies and Unresolved Issues -- 6.3.1 Burdens and Benefits -- 6.3.2 Participant Selection and Payment -- 6.3.3 Governance -- 6.4 Future Directions -- References.
author_facet Jamrozik, Euzebiusz.
Selgelid, Michael J.
author_variant e j ej
author2 Selgelid, Michael J.
author2_variant m j s mj mjs
author2_role TeilnehmendeR
author_sort Jamrozik, Euzebiusz.
title Human Challenge Studies in Endemic Settings : Ethical and Regulatory Issues.
title_sub Ethical and Regulatory Issues.
title_full Human Challenge Studies in Endemic Settings : Ethical and Regulatory Issues.
title_fullStr Human Challenge Studies in Endemic Settings : Ethical and Regulatory Issues.
title_full_unstemmed Human Challenge Studies in Endemic Settings : Ethical and Regulatory Issues.
title_auth Human Challenge Studies in Endemic Settings : Ethical and Regulatory Issues.
title_new Human Challenge Studies in Endemic Settings :
title_sort human challenge studies in endemic settings : ethical and regulatory issues.
series SpringerBriefs in Ethics Series
series2 SpringerBriefs in Ethics Series
publisher Springer International Publishing AG,
publishDate 2020
physical 1 online resource (145 pages)
edition 1st ed.
contents Intro -- Preface -- Acknowledgments -- Executive Summary -- Background -- Key Points of Consensus -- Unresolved Issues -- Conclusion -- Contents -- 1 Introduction -- 1.1 Focus of This Report -- 1.2 Methods -- 1.2.1 Literature Review -- 1.2.2 Qualitative Interviews -- 1.2.3 Synthesis and Validity Checking -- References -- 2 History of Human Challenge Studies -- 2.1 Experimental Infection in the 18th-19th Century -- 2.2 Early Challenge Studies with Vector-Borne Diseases -- 2.3 Malariotherapy -- 2.4 Infamous 20th Century Cases and the Rise of Modern Research Ethics -- 2.5 Late 20th Century -- 2.6 Capacity Building in Low- and Middle-Income Countries -- References -- 3 Ethical Issues -- 3.1 Intentional Infection -- 3.2 Benefits -- 3.2.1 Scientific Rationale and Social Value -- 3.2.2 Benefit Sharing -- 3.2.3 Capacity Building -- 3.2.4 Potential Individual Benefits of Participation in Endemic Settings -- 3.3 Burdens for Participants -- 3.3.1 Limits to Risk -- 3.3.2 Minimising Risks -- 3.3.3 Risks to Participants in Endemic Settings -- 3.3.4 Long-Term Risks and Lasting Harms -- 3.3.5 Uncertainty -- 3.3.6 Other Burdens for Participants -- 3.3.7 Participant Behaviour -- 3.4 Risks to Third Parties -- 3.4.1 Third-Party Risks and Studies of Transmissibility -- 3.5 Participant Selection -- 3.5.1 Vulnerable Populations in Human Challenge Studies -- 3.5.2 Consent -- 3.5.3 Education Level -- 3.5.4 Children -- 3.6 Payment of Participants -- 3.6.1 Undue Inducement -- 3.6.2 Other Ethical Issues Related to Payment -- References -- 4 Community Engagement, Ethics Review, and Regulation -- 4.1 Community Engagement -- 4.2 Ethical Review -- 4.2.1 Ethical Frameworks for Human Challenge Studies -- 4.2.2 Potential Models for Special Ethical Review -- 4.3 Regulation -- 4.3.1 International Regulations -- 4.3.2 Regulating Challenge Strains.
4.3.3 Challenge Studies and Licensure of New Interventions -- 4.3.4 Regulation of Over-Volunteering -- 4.3.5 Laws Criminalising Intentional Infection -- References -- 5 Case Studies: Challenge Studies in Low- and Middle-Income Countries -- 5.1 Cholera and Shigella Challenge Studies in Thailand -- 5.1.1 Rationale and Review Process -- 5.1.2 Recruitment, Participant Selection, Consent, and Payment -- 5.1.3 Burdens (Including Risks to Participants and Third Parties) -- 5.1.4 Summary and Outcomes -- 5.2 Falciparum Malaria Challenge Studies in Africa -- 5.2.1 Rationale and Review Process -- 5.2.2 Recruitment, Participant Selection, Consent, and Payment -- 5.2.3 Burdens (Including Risks to Participants and Third Parties) -- 5.2.4 Summary and Outcomes -- 5.3 Vivax Malaria Challenge Studies in Colombia -- 5.3.1 Rationale and Review Process -- 5.3.2 Recruitment, Participant Selection, Consent, and Payment -- 5.3.3 Burdens (Including Risks to Participants and Third Parties) -- 5.3.4 Summary and Outcomes -- 5.4 Summary of Case Studies -- 5.4.1 Rationale and Review Process -- 5.4.2 Recruitment, Participant Selection, Consent, and Payment -- 5.4.3 Burdens (Including Risks to Participants and Third Parties) -- References -- 6 Conclusions -- 6.1 Lessons Learned to Date -- 6.2 Points of Consensus -- 6.3 Controversies and Unresolved Issues -- 6.3.1 Burdens and Benefits -- 6.3.2 Participant Selection and Payment -- 6.3.3 Governance -- 6.4 Future Directions -- References.
isbn 9783030414801
9783030414795
callnumber-first Q - Science
callnumber-subject QH - Natural History and Biology
callnumber-label QH332
callnumber-sort QH 3332
genre Electronic books.
genre_facet Electronic books.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6310312
illustrated Not Illustrated
oclc_num 1243532476
work_keys_str_mv AT jamrozikeuzebiusz humanchallengestudiesinendemicsettingsethicalandregulatoryissues
AT selgelidmichaelj humanchallengestudiesinendemicsettingsethicalandregulatoryissues
status_str n
ids_txt_mv (MiAaPQ)5006310312
(Au-PeEL)EBL6310312
(OCoLC)1243532476
carrierType_str_mv cr
hierarchy_parent_title SpringerBriefs in Ethics Series
is_hierarchy_title Human Challenge Studies in Endemic Settings : Ethical and Regulatory Issues.
container_title SpringerBriefs in Ethics Series
author2_original_writing_str_mv noLinkedField
marc_error Info : MARC8 translation shorter than ISO-8859-1, choosing MARC8. --- [ 856 : z ]
_version_ 1792331056850927617
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05294nam a22004213i 4500</leader><controlfield tag="001">5006310312</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20240229073835.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">240229s2020 xx o ||||0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783030414801</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9783030414795</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5006310312</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL6310312</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1243532476</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QH332</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jamrozik, Euzebiusz.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Human Challenge Studies in Endemic Settings :</subfield><subfield code="b">Ethical and Regulatory Issues.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing AG,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2021.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (145 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">SpringerBriefs in Ethics Series</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro -- Preface -- Acknowledgments -- Executive Summary -- Background -- Key Points of Consensus -- Unresolved Issues -- Conclusion -- Contents -- 1 Introduction -- 1.1 Focus of This Report -- 1.2 Methods -- 1.2.1 Literature Review -- 1.2.2 Qualitative Interviews -- 1.2.3 Synthesis and Validity Checking -- References -- 2 History of Human Challenge Studies -- 2.1 Experimental Infection in the 18th-19th Century -- 2.2 Early Challenge Studies with Vector-Borne Diseases -- 2.3 Malariotherapy -- 2.4 Infamous 20th Century Cases and the Rise of Modern Research Ethics -- 2.5 Late 20th Century -- 2.6 Capacity Building in Low- and Middle-Income Countries -- References -- 3 Ethical Issues -- 3.1 Intentional Infection -- 3.2 Benefits -- 3.2.1 Scientific Rationale and Social Value -- 3.2.2 Benefit Sharing -- 3.2.3 Capacity Building -- 3.2.4 Potential Individual Benefits of Participation in Endemic Settings -- 3.3 Burdens for Participants -- 3.3.1 Limits to Risk -- 3.3.2 Minimising Risks -- 3.3.3 Risks to Participants in Endemic Settings -- 3.3.4 Long-Term Risks and Lasting Harms -- 3.3.5 Uncertainty -- 3.3.6 Other Burdens for Participants -- 3.3.7 Participant Behaviour -- 3.4 Risks to Third Parties -- 3.4.1 Third-Party Risks and Studies of Transmissibility -- 3.5 Participant Selection -- 3.5.1 Vulnerable Populations in Human Challenge Studies -- 3.5.2 Consent -- 3.5.3 Education Level -- 3.5.4 Children -- 3.6 Payment of Participants -- 3.6.1 Undue Inducement -- 3.6.2 Other Ethical Issues Related to Payment -- References -- 4 Community Engagement, Ethics Review, and Regulation -- 4.1 Community Engagement -- 4.2 Ethical Review -- 4.2.1 Ethical Frameworks for Human Challenge Studies -- 4.2.2 Potential Models for Special Ethical Review -- 4.3 Regulation -- 4.3.1 International Regulations -- 4.3.2 Regulating Challenge Strains.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4.3.3 Challenge Studies and Licensure of New Interventions -- 4.3.4 Regulation of Over-Volunteering -- 4.3.5 Laws Criminalising Intentional Infection -- References -- 5 Case Studies: Challenge Studies in Low- and Middle-Income Countries -- 5.1 Cholera and Shigella Challenge Studies in Thailand -- 5.1.1 Rationale and Review Process -- 5.1.2 Recruitment, Participant Selection, Consent, and Payment -- 5.1.3 Burdens (Including Risks to Participants and Third Parties) -- 5.1.4 Summary and Outcomes -- 5.2 Falciparum Malaria Challenge Studies in Africa -- 5.2.1 Rationale and Review Process -- 5.2.2 Recruitment, Participant Selection, Consent, and Payment -- 5.2.3 Burdens (Including Risks to Participants and Third Parties) -- 5.2.4 Summary and Outcomes -- 5.3 Vivax Malaria Challenge Studies in Colombia -- 5.3.1 Rationale and Review Process -- 5.3.2 Recruitment, Participant Selection, Consent, and Payment -- 5.3.3 Burdens (Including Risks to Participants and Third Parties) -- 5.3.4 Summary and Outcomes -- 5.4 Summary of Case Studies -- 5.4.1 Rationale and Review Process -- 5.4.2 Recruitment, Participant Selection, Consent, and Payment -- 5.4.3 Burdens (Including Risks to Participants and Third Parties) -- References -- 6 Conclusions -- 6.1 Lessons Learned to Date -- 6.2 Points of Consensus -- 6.3 Controversies and Unresolved Issues -- 6.3.1 Burdens and Benefits -- 6.3.2 Participant Selection and Payment -- 6.3.3 Governance -- 6.4 Future Directions -- References.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="590" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. </subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Selgelid, Michael J.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Jamrozik, Euzebiusz</subfield><subfield code="t">Human Challenge Studies in Endemic Settings</subfield><subfield code="d">Cham : Springer International Publishing AG,c2020</subfield><subfield code="z">9783030414795</subfield></datafield><datafield tag="797" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">SpringerBriefs in Ethics Series</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6310312</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>